Background T1-weighted magnetic resonance imaging (MRI) remains the standard pituitary imaging sequence. However, up to 50% of pituitary adenomas are missed with standard imaging in Cushing's disease (CD) patients. Utility of other imaging sequences needs be explored. Objective To compare a T2-gradient echo sequence, constructive interference in steady state (CISS), with a contrast-enhanced (CE) T1-weighted sequence, volume-interpolated breath-hold examination (VIBE), in the detection of pituitary adenomas in CD patients. Design Retrospective analysis of CD patients who underwent endoscopic transsphenoidal pituitary adenomectomy at our institution. Patients and Measurement Twelve patients were included in the study. Two neuroradiologists, who were blinded to the patients' clinical and surgical findings, independently reviewed the CE-VIBE and CISS images. Localization of pituitary adenoma from imaging was compared with intraoperative localization. Results The averaged sensitivity of detecting pituitary adenoma in CD patients was not significantly different between CE-VIBE sequence (63%) and CISS sequence (54%). The positive predictive value was 75% (Observer A) and 100% (Observer B) with CE-VIBE sequence, and 64% (Observer A) and 100% (Observer B) with CISS sequence. In two patients, pituitary adenoma was easily localized with CISS sequence but hard to detect with CE-VIBE sequence. In two other patients, the adenoma was much better delineated on CE-VIBE sequence. Conclusion In our series, the addition of CISS sequence to T1-weighted MRI imaging protocols improved the detection of pituitary adenomas in CD patients. CISS sequence may be a useful adjunct to T1-weighted pituitary MRI protocols and an appropriate alternative for patients with gadolinium contraindications.
Introduction
Cushing's disease (CD) is characterized by hypercortisolism produced by an adrenocorticotropic hormone (ACTH)-producing pituitary adenoma. It is the most common cause of endogenous Cushing's syndrome, accounting for 60 to 80% of cases.
1
Due to the complex anatomical architecture of the sella turcica and the resolution limitations of two-dimensional spin-echo sequences, conventional T1-weighted images of pituitary adenomas often do not show satisfactory morphological and anatomical details.
2 Furthermore, up to 50% of pituitary ACTH-secreting adenomas are not detected via T1-weighted magnetic resonance imaging (MRI).
3-5
Constructive interference in steady state (CISS) is a high spatial-resolution fast gradient echo sequence that accentuates T2 values and emphasizes water content signal, making it useful for evaluating small structures or pathologic structures surrounded by cerebrospinal fluid (CSF). CISS images appear to be heavily T2 weighted but actually have some degree of mixed T2 and T1 weighing. The image contrast of CISS sequence is dependent on the T2 to T1 relaxation time ratio, making CSF signal intensity greater than the brain parenchyma. Based on these properties, previous studies have shown that CISS is superior to T1-weighted sequences at visualizing cranial nerves, cisternal spaces, and parasellar extension by pituitary macroadenomas.
2,6-10 Furthermore, CISS sequence does not require the administration of contrast, and therefore, can be safely obtained in any patient able to undergo standard, nonenhanced imaging.
In this study, we compared the ability of CISS to a contrastenhanced T1-weighted MRI sequence, volume interpolated breath-hold examination (VIBE) at detecting pituitary adenomas in CD patients.
Subjects and Methods
A retrospective study was performed on 12 patients (11 females and 1 male) who were diagnosed with CD. All patients underwent primary endoscopic transsphenoidal pituitary adenomectomy by the senior author (PFR) between January 2014 and December 2015. In accordance to the Endocrine Society guidelines, patients were diagnosed with hypercortisolism/Cushing's syndrome by at least two of the three following tests: 24-hour urinary free cortisol, late night salivary cortisol, or low-dose dexamethasone suppression test.
11 ACTH levels were subsequently measured. When ACTH-dependent hypercortisolism was confirmed, a pituitary protocol MRI was obtained. Bilateral inferior petrosal sinus sampling (BIPSS) with corticotropin-releasing hormone (CRH) stimulation was performed in cases with unclear MRI results (no tumor or pituitary abnormality <6 mm). Histological staining of intraoperative biopsy samples was performed to confirm ACTH-secreting adenoma. The study was approved by Cleveland Clinic's Institutional Review Board.
Magnetic Resonance Imaging
Neuronavigation MRI protocol, with contrast-enhanced (CE)-VIBE and CISS sequences, was obtained in all patients after the clinical diagnosis of CD and prior to endoscopic transsphenoidal surgery. Dynamic sequence was not included as part of the standard preoperative imaging protocol at our institution, and therefore was not acquired for the patients. These particular sequences were obtained as they can be reconstructed in three dimensions, allowing them to be used for neuronavigation by the surgeon to confirm anatomical structures on imaging intraoperatively. Thus, these images were not obtained for initial diagnostic purposes. All MRI scans were performed in a 1.5 T scanner (Aera, Siemens, Erlangen, Germany). Two imaging techniques were included in the study: (1) axial and coronal CE-VIBE with repetition time/echo time of 9 ms/1.79 ms, 256 Â 256 matrix, 200 mm field of view, 0.8 mm thick interleaved slices without gap, 9°flip angle, 20% distance factor, and $4.9 minutes scan time; (2) axial and coronal CISS with repetition time/echo time of 5.84 ms/2.67ms, 256 Â 256 matrix, 200 mm field of view, 0.7 mm thick interleaved slices without gap, 42°flip angle, 20% distance factor, and $6.1 minutes scan time. Patients were administered 0.05 mmol/kg of gadolinium intravenous contrast for CE-VIBE, which is half the standard dose at most institutions.
Data Collection and Analysis
The images were reviewed by two neuroradiologists (Observer A, a neuroradiology fellow, and Observer B, a neuroradiology staff physician), who were blinded to the patients' clinical history and operative findings. Each independently reviewed the MRIs of two different sequences: CE-VIBE and CISS. Each reviewer was asked to evaluate the images for the presence of pituitary adenoma. Localization of pituitary adenomas from MRI results was compared with intraoperative surgical findings. Tumor size was measured only when the reported location of the tumor on MRI matched the intraoperative finding. The results of the two neuroradiologists were analyzed and listed independently. Tumor sizes were presented as mean AE standard deviation. The sensitivity of CE-VIBE and CISS was compared using McNemar's test.
Results

Tumor Identification
Observer A correctly identified a pituitary adenoma in 9 of 12 (75%) patients: seven cases of pituitary microadenoma, with an average size of 3.9 AE 2.2 mm, and two cases of macroadenoma, with an average size of 22.5 AE 17.7 mm. Observer B correctly identified a pituitary adenoma in 8 of 12 (67%) cases: six cases of microadenoma, with an average size of 6.5 AE 2.1 mm, and two cases of macroadenoma, with an average size of 24.5 AE 13.4 mm.
Imaging Outcomes
Pituitary adenomas exhibited decreased enhancement relative to surrounding pituitary parenchyma on CE-VIBE. In contrast, pituitary adenomas were hyperintense on CISS images. The imaging, BIPSS, and surgical localization of the 12 patients are listed independently in ►Table 1.
The sensitivities were calculated by comparing the imaging results to surgical findings. The sensitivities for detecting pituitary adenoma using CE-VIBE and CISS MR images were 75 and 58%, respectively, for Observer A; 50 and 50%, for Observer B (►Table 2). The averaged sensitivities for CE-VIBE and CISS were 63 and 54%, respectively (►Fig. 1). There was no significant difference between the sensitivity of CE-VIBE and CISS sequences (p ¼ 0.48 for Observer A; p ¼ 0.62 for Observer B). For Observer B, the sensitivity increased to 67% if CE-VIBE and CISS results were used in conjunction. Twenty-five percent (3 of 12 cases) and thirty-six percent (4 of 11 cases) of CE-VIBE and CISS findings from Observer A were false positives; meaning the pituitary adenoma localization from MRI findings did not match that of the surgical findings. Observer B did not have any false positives using CE-VIBE or CISS imaging.
In two patients (patient 5 and 8), the pituitary adenoma was much better delineated on CISS images than on CE-VIBE images (►Fig. 2). Adenoma localization of these two patients using CISS matched the intraoperative localization. Conversely, in two other patients, CE-VIBE sequence provided much better visualization of pituitary adenoma than CISS sequence (►Fig. 3). When pituitary adenoma was observable on both CE-VIBE and CISS images, the laterality concordance rate between the two sequences were 91 and 100% for Observer A and Observer B, respectively.
Bilateral Inferior Petrosal Sinus Sampling
BIPSS with CRH stimulation was performed in 6 of the 12 CD patients and confirmed a central source for ACTH hypersecretion in all cases (sensitivity of 100%). Petrosal venous sinus to peripheral ACTH ratio was calculated to determine adenoma laterality. The accuracy at predicting laterality was 67% (4 of 6 patients) (►Table 1).
Histological Findings and Surgical Outcome
Histopathology confirmed ACTH secreting pituitary adenoma in 11 of the 12 CD patients. Ten of the 12 patients developed adrenal insufficiency (cortisol < 2 μg/dL) postoperatively (►Table 1). The two patients with pituitary macroadenoma did not exhibit adrenal insufficiency and showed minimal decrease in serum cortisol level. One patient with negative histopathology did develop adrenal insufficiency postoperatively.
Discussion
In the present study, we compared the utility CISS MRI sequence to a contrast-enhanced T1-weighted MRI sequence at detecting pituitary adenomas in CD patients. We found that the sensitivity for pituitary adenoma detection was similar between the two sequences, but the detection rate increased when the two sequences were used in conjunction.
To the best of our knowledge, this is the first study to assess the usefulness of CISS sequence for preoperative evaluation of pituitary adenomas in CD patients. Surgery is the mainstay of treatment for CD. If left untreated, the estimated 5-year survival rate is $50%.
12,13 In comparison, 5-and 10-year survival rates after successful surgical resection have been reported to be 99 and 93%, respectively. 14 However, 20 to 30% of CD patients who undergo surgery do not achieve hormonal remission due to diagnostic errors, small tumors, or tumor invasion into adjacent tissues. 15, 16 Studies have reported improved remission rates when the tumor can be localized through preoperative MRI. 17, 18 It has also been suggested that surgical complications such as CSF leak are less prevalent when preoperative tumor localization is possible. 19 Being able to localize on imaging allows for better surgical planning and decreases the risk of pituitary damage due to unnecessary exploration.
20
Conventional T1-weighted MRI has a reported sensitivity of 50 to 60% for detecting pituitary adenomas in CD. 16, 21 In a more recent study of 57 CD patients, the sensitivity was only 37.5%. 22 To improve detection, other imaging modalities such as dynamic MRI and CE-VIBE have been explored. Dynamic MRI allows imaging of the pituitary during the early phases of contrast enhancement. While dynamic MRI did increase the detection of microadenomas in CD patients, the false-positive rate was higher than conventional T1-weighted MRI. 4,23,24 CE-VIBE was also found to be superior to conventional T1-weighted MRI for detecting pituitary adenoma in CD patients, with a reported sensitivity of 75 to 80%. 25 Thin sections, fast acquisition time that minimizes motion artifacts, and good soft tissue contrast make CE-VIBE particularly useful at detecting pituitary microadenomas in CD. 25 In our cohort, however, the averaged sensitivity between two observers was 63% using CE-VIBE imaging. This difference may be due to the small number of patients in our cohort and the different stringency used for adenoma identification across studies. Nevertheless, our findings support the use of CE-VIBE for localization of pituitary adenomas in CD patients. CISS sequence, also known as FIESTA (Fast Imaging Employing Steady-state Acquisition Cycled Phases) on GE (General Electric, Milwaukee, Wisconsin, United States), has been shown to be useful in investigating a variety of pathologies involving the pituitary stalk, skull-base tumors, cranial nerve disorders, neurocysticercosis, and diseases of the spine and spinal cord. 6 Its high signal-to-noise ratio and insensitivity to motion make it a useful imaging tool. Furthermore, CISS obtained at submillimetric thickness can provide more detailed visualization of the suprasellar compartment due to good contrast between CSF and the surrounding structures.
26
While CISS imaging has been shown to be effective at predicting pituitary macroadenoma consistently, its ability to detect pituitary adenoma in CD patients has never been reported.
10,27
In our patient cohort, we found that CISS sequence had a similar, albeit slightly lower, sensitivity to CE-VIBE at detecting pituitary adenoma in CD patients (►Fig. 1). Interestingly, 2 out of the 12 CD patients in our study had pituitary adenomas that were isointense and difficulty to visualize on CE-VIBE, but were easily localized on CISS images (►Fig. 2). The opposite was true for two other patients (►Fig. 3). This suggests that CE-VIBE and CISS may be good complimentary sequences. Furthermore, the sensitivity of detecting pituitary adenoma for Observer B improved by 17% when CISS sequence results were used in conjunction with CE-VIBE results. Accurate localization of the adenomas in all cases was helpful in establishing the surgical approach and preoperative planning. We think CISS may be of value as an adjunct sequence to CE-VIBE for the workup of CD. Furthermore, CISS sequence does not require contrast enhancement. Therefore, it may even be an appropriate alternative to T1-weighted sequences in patients with gadolinium contraindications, such as those with renal dysfunction or chronic renal failure. [28] [29] [30] Interestingly, we found no correlation between the histopathology, the location, or adenoma size and which sequence the adenoma was better visualized with. This remains an interesting topic for future studies with a more robust sample size.
Inter-rater discrepancy of MRI reporting was noted in our study. The more experienced of the two neuroradiologists (Observer B) had greater accuracy at pituitary adenoma localization, with no false positives with CE-VIBE or CISS sequences (►Table 2). This was not surprising as the additional years of experience likely contributed to the more conservative but also more accurate calls. Moreover, inter-rater differences are not uncommon when assessing pituitary pathologies through imaging.
31,32
A limitation of our study is the cohort size. A larger patient cohort is necessary to better compare the sensitivities of CE-VIBE and CISS sequences to detect pituitary adenomas in CD patients.
Conclusion
CISS sequence and the T1-weighted VIBE sequence had comparable sensitivity at detecting pituitary adenoma in CD patients and the addition of CISS sequence to T1-weighted MRI imaging protocols improved the detection of pituitary adenomas in CD patients in our series. CISS sequence may be a useful adjunct to T1-weighted pituitary MRI protocols and an appropriate alternative for patients with gadolinium contraindications.
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